RSPH1 Gene Primary Ciliary Dyskinesia Type 24 NGS Genetic DNA Test
Introduction
The RSPH1 Gene Primary Ciliary Dyskinesia Type 24 NGS Genetic DNA Test is a revolutionary diagnostic tool that helps in identifying genetic mutations associated with primary ciliary dyskinesia (PCD). This condition affects the cilia, the tiny hair-like structures that help clear mucus and debris from the respiratory tract. Understanding your genetic predisposition to PCD is crucial for early diagnosis and management.
What the Test Measures
This test specifically detects mutations in the RSPH1 gene, which can lead to dysfunction of cilia, resulting in various respiratory complications and ENT disorders. By analyzing the genetic material, we can determine if a patient is at risk of developing these conditions.
Who Should Consider This Test
Individuals experiencing chronic respiratory infections, sinusitis, or hearing loss may benefit from this test. Additionally, those with a family history of PCD or related disorders should consider genetic testing to assess their risk.
Benefits of Taking the Test
- Early diagnosis of primary ciliary dyskinesia.
- Informed management strategies for respiratory health.
- Guidance on family planning and genetic counseling.
- Access to specialized care and treatment options.
Understanding Your Results
Results from the RSPH1 Gene Primary Ciliary Dyskinesia Type 24 NGS Genetic DNA Test will be available within 3 to 4 weeks. A genetic counselor will help interpret the findings and discuss the implications for you and your family.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| RSPH1 Gene Primary Ciliary Dyskinesia Type 24 NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Convenient Testing Across Kenya
We have branches across all major cities in Kenya and offer home sample collection services for your convenience. Book the RSPH1 Gene Primary Ciliary Dyskinesia Type 24 NGS Genetic DNA Test today by calling or WhatsApp us at +254711564616.
